Patient perspective on watchful waiting/active surveillance for localized prostate cancer
- PMID: 23136314
- PMCID: PMC4212643
- DOI: 10.3122/jabfm.2012.06.120128
Patient perspective on watchful waiting/active surveillance for localized prostate cancer
Abstract
Objective: To describe prostate cancer treatment decision making, focusing on knowledge and attitudes toward observation, known as watchful waiting (WW) or active surveillance (AS), and reasons for not choosing WW/AS.
Methods: Semistructured in-person interviews were conducted with 21 men (14 black; 7 white) with recently diagnosed localized prostate cancer.
Results: All cancers were detected by prostate-specific antigen screening; 14 men had low-risk disease. Nineteen chose surgery or radiation treatment. The majority wanted to "get rid of" or "cure" the cancer by undergoing aggressive therapy, even with awareness of the potential for significant side effects. Most men seemed unaware of the uncertainty/controversies that aggressive treatment may not cure their cancer or improve their survival. Limited knowledge about WW/AS was common, and few remembered WW/AS being presented as a viable option. Rather, many men perceived it as "doing nothing." Some men, who initially were inclined toward WW/AS, yielded to pressure from family, physicians, or both to choose aggressive treatment. Lack of physician support was a significant barrier to WW/AS.
Conclusions: The observational strategy (WW/AS) was not viewed as a reasonable approach, even for those with low-risk cancer. The desire for aggressive therapy may reflect the complex psychology associated with receiving a diagnosis of cancer and the limited supportive counseling received. Further efforts to better understand and educate patients and physicians may help men make informed and appropriate treatment decisions to maximize quality of life without compromising survival.
Conflict of interest statement
Similar articles
-
Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.J Racial Ethn Health Disparities. 2016 Mar;3(1):35-45. doi: 10.1007/s40615-015-0109-8. Epub 2015 May 5. J Racial Ethn Health Disparities. 2016. PMID: 26896103 Free PMC article.
-
Men's perspectives on selecting their prostate cancer treatment.J Natl Med Assoc. 2011 Jun;103(6):468-78. doi: 10.1016/s0027-9684(15)30359-x. J Natl Med Assoc. 2011. PMID: 21830629 Free PMC article.
-
Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.Eur Urol. 2017 Dec;72(6):899-907. doi: 10.1016/j.eururo.2017.07.018. Epub 2017 Aug 23. Eur Urol. 2017. PMID: 28844371 Free PMC article.
-
Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.Semin Urol Oncol. 2002 Feb;20(1):10-7. doi: 10.1053/suro.2002.30393. Semin Urol Oncol. 2002. PMID: 11828353 Review.
-
Critical review: is watchful waiting a viable management option for older men with prostate cancer?Am J Mens Health. 2007 Mar;1(1):18-28. doi: 10.1177/1557988306294161. Am J Mens Health. 2007. PMID: 19482780 Review.
Cited by
-
A lifestyle intervention among elderly men on active surveillance for non-aggressive prostate cancer: a randomised feasibility study with whole-grain rye and exercise.Trials. 2017 Jan 13;18(1):20. doi: 10.1186/s13063-016-1734-1. Trials. 2017. PMID: 28086943 Free PMC article. Clinical Trial.
-
Patient and provider experiences with active surveillance: A scoping review.PLoS One. 2018 Feb 5;13(2):e0192097. doi: 10.1371/journal.pone.0192097. eCollection 2018. PLoS One. 2018. PMID: 29401514 Free PMC article.
-
'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.Psychooncology. 2014 Apr;23(4):467-72. doi: 10.1002/pon.3444. Epub 2013 Nov 14. Psychooncology. 2014. PMID: 24243777 Free PMC article.
-
The importance of perceived stress management skills for patients with prostate cancer in active surveillance.J Behav Med. 2015 Apr;38(2):214-23. doi: 10.1007/s10865-014-9594-1. Epub 2014 Sep 19. J Behav Med. 2015. PMID: 25234859 Free PMC article.
-
Active surveillance for prostate cancer: a narrative review of clinical guidelines.Nat Rev Urol. 2016 Mar;13(3):151-67. doi: 10.1038/nrurol.2015.313. Epub 2016 Jan 27. Nat Rev Urol. 2016. PMID: 26813955 Review.
References
-
- Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605–13. - PubMed
-
- Roemeling S, Roobol MJ, de Vries SH, et al. Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics. PSA doubling times, and outcome. Eur Urol. 2007;51:1244–51. - PubMed
-
- Draisma G, Boer R, Otto SJ, et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst. 2003;95:868–78. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials